Medgen signs radio ad campaign with leading global media firm with a reach of 858 million consumers
HOLBROOK, N.Y., July 29, 2015 /PRNewswire/ -- Medgen, Inc. (OTCPink: MDIN) today announced that it has signed a preliminary advertising deal with iHeartMEDIA® to run radio ads for SNORenz®, anti-snoring spray on its network which comprises some of the most popular radio stations in the country.
The radio spot is basically the audio track to the company's popular video advertisement released recently, which was written to serve as the soundtrack for the TV commercial as well as a stand-alone radio spot. The spots will air on various stations in the network at different times to gauge consumer reaction. iHeartMEDIA's radio network is immense and includes extremely popular stations like Kiss FM, FOX Sports, and News Talk, which is the home of popular radio programming like the Glenn Beck Show and Sean Hannity. Starting in local markets like Phoenix and then expanding from there, the total potential coverage is approximately 858 radio stations in 150 different markets reaching 250 million monthly listeners.
"We have a clever advertisement and we're starting by running it in a major market. 4.3 million people live in the Phoenix, AZ area. That's the type of coverage we're looking for. The goal is for SNORenz® ads to be running around the clock in every major market." said Medgen CEO, Brandon Dean.
Once the initial campaign numbers are in, the company will refine the ad if necessary, and be better prepared for the execution of the full-scale radio ad campaign. The radio campaigns are part of a much bigger plan, coupled with TV spots, print and other media to capture as much of the market share as possible in the shortest amount of time. Since shipping to retail stores started earlier in the month, the company feels it is important to create brand awareness to prime each market for retail release, and to support the retail sales as the company expands into those markets. The company is currently awaiting a full store list as well as feedback and reaction from the retail community in its initial roll out of SNORenz® counter top displays, and will share this information with the public as it receives it. All of these advances create a great launching point for the company's newest addition, Wide Awake™, a unique energy spray that many people think has the potential to dominate the $37 billion energy drink market, as well as several other projects aimed at increasing brand awareness, gaining market share, and ensuring continued growth moving forward. For more information people are encouraged to visit the company's website at www.medgeninc.com and follow the company on twitter at @medgeninc.
About Medgen, Inc.
Medgen is dedicated to producing the best alternative healthcare products to the world. The company's products include SNORenz®, SNORenz Night Time™, Stem-Intense™, and more. Most of the company's products use a unique or patented spray delivery system, and all have received rave consumer reviews all over the world, selling millions of units from 1996 to the present.
DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements
SOURCE Medgen, Inc.
Share this article